Hakutulokset - Annette Ervin‐Haynes

  • Näytetään 1 - 5 yhteensä 5 tuloksesta
Tarkenna hakua
  1. 1
    Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

    Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma Tekijä Thomas M. Habermann, Izidore S. Lossos, Glen R. Justice, Julie M. Vose, Peter H. Wiernik, Kyle McBride, Kenton Wride, Annette Ervin‐Haynes, Kenichi Takeshita, Dennis Pietronigro, Jerome B. Zeldis, Joseph M. Tuscano

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

    Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Tekijä Thomas E. Witzig, Peter H. Wiernik, Timothy D. Moore, Craig B. Reeder, Craig E. Cole, Glen R. Justice, Henry G. Kaplan, Michael Voralia, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin‐Haynes, Jerome B. Zeldis, Julie M. Vose

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

    Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Tekijä Peter H. Wiernik, Izidore S. Lossos, Joseph M. Tuscano, Glen R. Justice, Julie M. Vose, Craig E. Cole, Wwt Lam, Kyle McBride, Kenton Wride, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin‐Haynes, Jerome B. Zeldis, Thomas M. Habermann

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

    Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma Tekijä Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R. Belch, Michèle Cavo, Antonio Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darrell White, Daniel Binder, Kenneth Anderson, Jean-Paul Fermand, Philippe Moreau, Michel Attal, Robert Knight, Guang Chen, Jason Van Oostendorp, Christian Jacques, Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

    Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma Tekijä Thierry Façon, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew Belch, Michèle Cavo, Antonio Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Aurore Perrot, Bertrand Arnulf, Lugui Qiu, Murielle Roussel, Eileen M. Boyle, Salomon Manier, Mohamad Mohty, Hervé Avet‐Loiseau, Xavier Leleu, Annette Ervin‐Haynes, Guang Chen, Vanessa Houck, Lotfi Benboubker, Cyrille Hulin

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: